Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis.

Chang SH, Choi BY, Choi J, Yoo JJ, Ha YJ, Cho HJ, Kang EH, Song YW, Lee YJ.

Rheumatol Int. 2015 Jan;35(1):71-9. doi: 10.1007/s00296-014-3056-5. Epub 2014 Jun 11.

PMID:
25027626
2.

Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis.

Terao C, Yamakawa N, Yano K, Markusse IM, Ikari K, Yoshida S, Furu M, Hashimoto M, Ito H, Fujii T, Ohmura K, Murakami K, Takahashi M, Hamaguchi M, Tabara Y, Taniguchi A, Momohara S, Raychaudhuri S, Allaart CF, Yamanaka H, Mimori T, Matsuda F.

Arthritis Rheumatol. 2015 Dec;67(12):3113-23. doi: 10.1002/art.39306.

3.

Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.

Meeuwisse CM, van der Linden MP, Rullmann TA, Allaart CF, Nelissen R, Huizinga TW, Garritsen A, Toes RE, van Schaik R, van der Helm-van Mil AH.

Arthritis Rheum. 2011 May;63(5):1265-73. doi: 10.1002/art.30273.

4.

The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.

Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, Nilsson JÅ, Forslind K, Albertsson K, Rönnelid J, Petersson IF.

Scand J Rheumatol. 2011 Mar;40(2):81-7. doi: 10.3109/03009742.2010.509103. Epub 2010 Oct 5.

PMID:
20919947
5.

Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.

Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK.

Scand J Rheumatol. 2016 Jul;45(4):274-81. doi: 10.3109/03009742.2015.1107128. Epub 2016 Jan 15.

PMID:
26767827
6.

Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.

Meyer M, Sellam J, Fellahi S, Kotti S, Bastard JP, Meyer O, Lioté F, Simon T, Capeau J, Berenbaum F.

Arthritis Res Ther. 2013;15(6):R210.

7.

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM.

Arthritis Rheum. 2009 Jul;60(7):1906-14. doi: 10.1002/art.24626.

8.

Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.

Moon SJ, Hong YS, Ju JH, Kwok SK, Park SH, Min JK.

J Rheumatol. 2013 Nov;40(11):1842-9. doi: 10.3899/jrheum.130356. Epub 2013 Sep 1.

PMID:
23996288
9.

Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, FitzGerald O, Poole AR, Bresnihan B, Veale DJ, Fearon U.

Arthritis Rheum. 2012 Apr;64(4):1035-45. doi: 10.1002/art.33455. Epub 2011 Nov 10.

10.

Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up.

Houseman M, Potter C, Marshall N, Lakey R, Cawston T, Griffiths I, Young-Min S, Isaacs JD.

Arthritis Res Ther. 2012 Feb 7;14(1):R30. doi: 10.1186/ar3734.

11.

Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis.

Grandaunet B, Syversen SW, Hoff M, Sundan A, Haugeberg G, van Der Heijde D, Kvien TK, Standal T.

Arthritis Rheum. 2011 Mar;63(3):662-9. doi: 10.1002/art.30163.

12.

Cigarette smoking and radiographic progression in rheumatoid arthritis.

Finckh A, Dehler S, Costenbader KH, Gabay C; Swiss Clinical Quality Management project for RA..

Ann Rheum Dis. 2007 Aug;66(8):1066-71. Epub 2007 Jan 19.

13.

Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.

van Nies JA, van Steenbergen HW, Krabben A, Stomp W, Huizinga TW, Reijnierse M, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 May;74(5):883-9. doi: 10.1136/annrheumdis-2013-204659. Epub 2014 Jan 15.

PMID:
24431393
14.

The prognostic value of baseline erosions in undifferentiated arthritis.

Thabet MM, Huizinga TW, van der Heijde DM, van der Helm-van Mil AH.

Arthritis Res Ther. 2009;11(5):R155. doi: 10.1186/ar2832. Epub 2009 Oct 15.

15.

The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.

Kragstrup TW, Greisen SR, Nielsen MA, Rhodes C, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Vorup-Jensen T, Robinson WH, Sokolove J, Deleuran B.

Arthritis Res Ther. 2016 Mar 11;18:61. doi: 10.1186/s13075-016-0964-7.

16.

The association of radiographic progression with serum R-spondin 1 (RSPO1) levels or Dickkopf-1 (DKK1)/RSPO1 ratios in rheumatoid arthritis patients: clinical evidence for reciprocal inhibition between DKK1 and RSPO1.

Choi BY, Chang SH, Cho HJ, Kang EH, Shin K, Song YW, Lee YJ.

Scand J Rheumatol. 2014;43(6):453-61. doi: 10.3109/03009742.2014.905629. Epub 2014 Sep 2.

PMID:
25178409
17.

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF.

Ann Rheum Dis. 2015 Jun;74(6):1102-9. doi: 10.1136/annrheumdis-2013-204986. Epub 2014 May 8.

18.

Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.

Hammer HB, Ødegård S, Syversen SW, Landewé R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK.

Ann Rheum Dis. 2010 Jan;69(1):150-4. doi: 10.1136/ard.2008.103739.

PMID:
19095696
20.

A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis.

de Rooy DP, Zhernakova A, Tsonaka R, Willemze A, Kurreeman BA, Trynka G, van Toorn L, Toes RE, Huizinga TW, Houwing-Duistermaat JJ, Gregersen PK, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Jun;73(6):1163-9. doi: 10.1136/annrheumdis-2013-203375. Epub 2013 May 21.

PMID:
23696630

Supplemental Content

Support Center